These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
591 related articles for article (PubMed ID: 17621564)
1. Stability issues of parenteral chemotherapy drugs. de Lemos ML; Hamata L J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564 [TBL] [Abstract][Full Text] [Related]
2. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists. Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879 [No Abstract] [Full Text] [Related]
3. Premixed intravenous admixtures: a positive development for hospital pharmacy. Lee HE Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393 [TBL] [Abstract][Full Text] [Related]
4. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives. Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428 [TBL] [Abstract][Full Text] [Related]
5. Premixed intravenous admixtures: a critical challenge for hospital pharmacy. Loeb AJ; Fishman DA; Kochis TR Am J Hosp Pharm; 1983 Jun; 40(6):1041-3. PubMed ID: 6869392 [TBL] [Abstract][Full Text] [Related]
6. Quality control guidelines for single unit packaging of parenterals in the hospital pharmacy. Patel JA; Curtis EG; Phillips GL Am J Hosp Pharm; 1972 Nov; 29(11):947-51. PubMed ID: 4655003 [No Abstract] [Full Text] [Related]
7. Recommendations to pharmacists for solving problems with large-volume parenterals. Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199 [No Abstract] [Full Text] [Related]
8. Guidelines for the practical stability studies of anticancer drugs: a European consensus conference. Bardin C; Astier A; Vulto A; Sewell G; Vigneron J; Trittler R; Daouphars M; Paul M; Trojniak M; Pinguet F; Ann Pharm Fr; 2011 Jul; 69(4):221-31. PubMed ID: 21840442 [TBL] [Abstract][Full Text] [Related]
9. Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial. André P; Cisternino S; Chiadmi F; Toledano A; Schlatter J; Fain O; Fontan JE Ann Pharmacother; 2005 Sep; 39(9):1462-6. PubMed ID: 15985470 [TBL] [Abstract][Full Text] [Related]
10. Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973 [TBL] [Abstract][Full Text] [Related]
11. Editorial: Solving problems associated with large-volume parenterals. I: pharmacist responsibility for compounding intravenous admixtures. Zellmer WA Am J Hosp Pharm; 1975 Mar; 32(3):255. PubMed ID: 1136972 [No Abstract] [Full Text] [Related]
12. Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under in-use Conditions with Different Administration Materials. Mueller C; Dietel E; Heynen SR; Nalenz H; Goldbach P; Mahler HC; Schmidt J; Grauschopf U; Schoenhamnmer K Int J Pharm Compd; 2015; 19(3):261-7. PubMed ID: 26714367 [TBL] [Abstract][Full Text] [Related]
13. Drug stability and compatibility in oncology care. Williams DA J Infus Chemother; 1996; 6(4):195-202. PubMed ID: 9229315 [TBL] [Abstract][Full Text] [Related]
14. Stability of antineoplastic agents in use for home-based intravenous chemotherapy. Benizri F; Bonan B; Ferrio AL; Brandely ML; Castagné V; Théou-Anton N; Verlinde-Carvalho M; Havard L Pharm World Sci; 2009 Feb; 31(1):1-13. PubMed ID: 19067224 [TBL] [Abstract][Full Text] [Related]
15. A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'. Kaestner S; Sewell G J Oncol Pharm Pract; 2007 Jun; 13(2):119-26. PubMed ID: 17873112 [TBL] [Abstract][Full Text] [Related]
17. Influence of compounding on sterility and stability of drugs. Hardee GE J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582 [No Abstract] [Full Text] [Related]
18. Current perspectives on stability of protein drug products during formulation, fill and finish operations. Rathore N; Rajan RS Biotechnol Prog; 2008; 24(3):504-14. PubMed ID: 18484778 [TBL] [Abstract][Full Text] [Related]
19. Survey of sterile product compounding practices in Canadian hospital pharmacies. Fitch DP; Hall KW Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343 [TBL] [Abstract][Full Text] [Related]
20. Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of quality? Glass B; Mangan M; Haywood A J Clin Pharm Ther; 2009 Apr; 34(2):161-9. PubMed ID: 19250136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]